X-Linked Retinitis Pigmentosa (XLRP) Clinical Trials in Cincinnati, Ohio

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa